ABIOMED Inc | Business Contracts

First Amendment, effective as of December 21, 2022, to the Change of Control Severance Agreement, effective as of April 6, 2018, by and between ABIOMED, Inc. and Todd Trapp (Filed With SEC on December 22, 2022)

Letter Agreement, dated as of October 31, 2022, between ABIOMED, Inc. and Michael R. Minogue (Filed With SEC on November 1, 2022)

Form of Contingent Value Rights Agreement, by and among Johnson & Johnson and a rights agent mutually acceptable to Johnson & Johnson and ABIOMED, Inc (Filed With SEC on November 1, 2022)

Agreement and Plan of Merger, dated as of October 31, 2022, by and among ABIOMED, Inc., Johnson & Johnson, and Athos Merger Sub, Inc (Filed With SEC on November 1, 2022)

Form of Indemnification Agreement (Filed With SEC on August 13, 2021)

Retention Agreement, dated as of October 31, 2022, between ABIOMED, Inc. and Andrew Greenfield (Filed With SEC on November 1, 2022)

Form Time-Based RSU Agreement (Executive Officer) under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on August 4, 2022)

Form Performance-Based RSU Agreement (Executive Officer) under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on August 4, 2022)

Form Performance-Based PSU Option Agreement (Executive Officer) under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on May 20, 2022)

Form of Executive Officer Performance-Based PSU Agreement under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on August 5, 2021)

Form of Executive Officer Time-Based Stock Option Agreement under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on August 5, 2021)

Form of Executive Officer Time-Based RSU Agreement under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on August 5, 2021)

Change of Control Severance Agreement between ABIOMED, Inc and Andrew J. Greenfield dated September 15, 2008 (Filed With SEC on May 21, 2021)

Change of Control Severance Agreement between ABIOMED, Inc and Marc A. Began dated November 1, 2018 (Filed With SEC on May 21, 2021)

Offer letter with Marc A. Began dated May 11, 2018 (Filed With SEC on May 21, 2021)

Form of Executive Officer Performance-Based PSU Agreement under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on February 4, 2021)

Form of Chief Executive Officer Performance-Based PSU Agreement under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on February 4, 2021)

Form of Executive Officer Performance-Based PSU Agreement under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on November 6, 2020)

Form of Executive Officer Time-Based Stock Option Agreement under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on November 6, 2020)

Form of Executive Officer Time-Based RSU Agreement under the Second Amended and Restated 2015 Omnibus Incentive Plan (Filed With SEC on November 6, 2020)

Letter Agreement dated April 27, 2020 with Executive Officers relates to salary reduction (Filed With SEC on May 21, 2020)

Letter Agreement dated April 27, 2020 with David Weber related to salary waiver (Filed With SEC on May 21, 2020)

Letter Agreement dated April 27, 2020 with Michael R. Minogue related to salary waiver (Filed With SEC on May 21, 2020)

Description of Common Stock (Filed With SEC on May 21, 2020)

Consulting Agreement (Filed With SEC on June 3, 2019)

1988 Employee Stock Purchase Plan, as Amended and Restated February 5, 2019 (Filed With SEC on May 23, 2019)

Description of Common Stock (Filed With SEC on May 23, 2019)

ABIOMED Inc (27)